Fujian Wanchen Biotechnology Co. Ltd (300972) — Capital Reinvestment Ratio
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥3.63 Billion) in capital expenditures (CN¥77.44 Million). Check tangible net worth ratio of Fujian Wanchen Biotechnology Co. Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fujian Wanchen Biotechnology Co. Ltd Capital Reinvestment Ratio (2019–2025)
This chart tracks Fujian Wanchen Biotechnology Co. Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Fujian Wanchen Biotechnology Co. Ltd.
Annual Capital Reinvestment Ratio for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year Capital Reinvestment Ratio for Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. See 300972 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥3.63 Billion | CN¥77.44 Million | ▼ -84.5% |
| 2024 | 0.14x | CN¥848.35 Million | CN¥116.65 Million | ▼ -35.7% |
| 2023 | 0.21x | CN¥1.02 Billion | CN¥218.91 Million | ▼ -95.2% |
| 2022 | 4.49x | CN¥70.38 Million | CN¥316.34 Million | ▲ +968.4% |
| 2021 | 0.42x | CN¥98.82 Million | CN¥41.57 Million | ▲ +17.2% |
| 2020 | 0.36x | CN¥156.24 Million | CN¥56.10 Million | ▲ +60.2% |
| 2019 | 0.22x | CN¥177.28 Million | CN¥39.73 Million | — |